FDA Clears Personal ECG Device for Measurement of QTc Interval, a Critical Marker for Patient Safety

MOUNTAIN VIEW, Calif.: MOUNTAIN VIEW, Calif., July 8, 2021 /PRNewswire/ -- AliveCor, the global leader in FDA-cleared personal electrocardiogram (ECG) technology and services, today announced it received 510(k) clearance by the U.S. Food and Drug Administration (FDA) for healthcare professionals to use the KardiaMobile 6L device to calculate patients' QTc...

Click to view original post